Investigation on the association between atopic dermatitis and the development of mycosis fungoides in dogs: A retrospective case-control study

Veterinary Dermatology

Volumn 18, Issue 2, 2007, Pages 101-106

  Santoro, D ^a   Marsella, R ^b   Hernandez, J ^b  

^a University of Florida ^*

^b University of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; ATOPIC DERMATITIS; CASE CONTROL STUDY; DOG; DOG DISEASE; FEMALE; INFORMATION PROCESSING; MALE; MYCOSIS FUNGOIDES; RETROSPECTIVE STUDY; SKIN TUMOR; UNITED STATES;

ANIMALS; CASE-CONTROL STUDIES; DERMATITIS, ATOPIC; DOG DISEASES; DOGS; FEMALE; FLORIDA; MALE; MYCOSIS FUNGOIDES; RECORDS; RETROSPECTIVE STUDIES; SKIN NEOPLASMS;

CANIS FAMILIARIS;

EID: 33847775471     PISSN: 09594493     EISSN: 13653164     Source Type: Journal    
DOI: 10.1111/j.1365-3164.2007.00582.x     Document Type: Article

References (63)

1. Moore PF, Olivry T, Naydan D. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T-cells. American Journal of Pathology 1994; 144: 421-9.
2. Scarisbrick JJ. Staging and management of cutaneous T-cell lymphoma. Clinical and Experimental Dermatology 2006; 31: 181-6.
3. Goldschmidt MH, Shofer F. Skin Tumors of the Dog and Cat. Pergamon Press: New York, 1992.
4. Gross TL, Ihrke PJ, Walder EJ. Veterinary Dermatopathology. A Macroscopic and Microscopic Evaluation of Canine and Feline Skin Diseases. St. Louis: Mosby-Year Book 1992.
5. Scott DW, Miller WH, Griffin CE, Eds. Lymphohistiocytic neoplasms. In: Muller and Kirk's Small Animal Dermatology. Philadelphia, PA: W.B. Saunders, 2001; 1330-57.
6. Kerl H, Cerroni L, Burg G. The morphologic spectrum of T-cell lymphomas of the skin: a proposal for a new classification. Seminars in Diagnostic Pathology 1991; 8: 55-61.
7. Hoppe RT, Wood GS, Abel EA. Mycosis fungoides and the Sezary syndrome: pathology, staging and treatment. In: Haskell CM, ed. Current Problems in Cancer. St. Louis: Mosby Year Book, 1990; 297-361.
8. Kuzel TM, Roenigk HH Jr, Rosen ST. Mycosis fungoides and Sezary syndrome: a review of pathogenesis, diagnosis, and therapy. Journal of Clinical Oncology 1991; 9: 1298-313.
9. Nickoloff BJ. Light-microscopic assessment of 100 patients with patch/plaque-stage mycosis fungoides. American Journal of Dermatopathology 1998; 10: 469-77.
10. Pielop JA, Jones D, Duvic M. Transient CD30+ nodal transformation of cutaneous T-cell lymphoma associated with cyclosporine treatment. International Journal of Dermatology 2001; 40: 505-11.
11. Fletcher CL, Orchard GE, Whittaker SJ et al. CD30+ cutaneous lymphoma in association with atopic eczema. Archives of Dermatology 2004; 140: 449-54.
12. Lange-Vejlsgaard G, Ralfkiaer E, Larsen JK et al. Fatal cutaneous t cell lymphoma in a child with atopic dermatitis. Journal of American Academy of Dermatology 1989; 20: 954-8.
13. Rajka G, Winkelmann RK. Atopic dermatitis and Sezary syndrome. Archives of Dermatology 1984; 120: 83-4.
14. Van Haselen CW, Toonstra J, Preesman AH et al. Sezary syndrome in a young man with severe atopic dermatitis. British Journal of Dermatology 1999; 140: 704-7.
15. Abel EA, Nickoloff BJ, Shelby DM et al. Tumor stage mycosis fungoides in a patient treated with long-term corticosteroids for asthma and atopic-like dermatitis. Journal of Dermatology Surgeon Oncology 1986; 12: 1089-93.
16. Hillier A, Griffin CE. The ACVD task force on canine atopic dermatitis (I): incidence and prevalence. Veterinary Immunology and Immunopathology 2001; 81: 147-51.
17. Teixeira F, Ortiz-Plata A, Cortes-Franco R et al. Do environmental factors play any role in the pathogenesis of mycosis fungoides and Sezary syndrome? International Journal of Dermatology 1994; 33 (11): 770-2.
18. Burg G, Kempf W, Haeffner A et al. From inflammation to neoplasia: new concepts in the pathogenesis of cutaneous lymphomas. Recent Results in Cancer Research 2002; 160: 271-80.
19. Burg G, Dummer R, Haeffner A et al. From inflammation to neoplasia. Archives of Dermatology 2001; 137: 949-52.
20. Tuyp E, Burgoyne A, Aitchison T et al. A case-control study of possible causative factors in mycosis fungoides. Archives of Dermatology 1987; 123: 196-200.
21. Whittemore AS, Holly EA, Min Lee I et al. Mycosis fungoides in relation to environmental exposures and immune response: a case-control study. Journal of National Cancer Institute 1989; 81: 1560-7.
22. Meharany K, El-Azhary RA, Bouwhuis SA et al. Cutaneous T-cell lymphoma and atopy: is there an association? British Journal of Dermatology 2003; 149: 1013-7.
23. Morales Suarez-Varela MM, Llopis Gonzalez A, Marquina Vila A et al. Review of epidemiological observations. Dermatology 2000; 201: 21-8.
24. Dohoo I, Martin W, Stryhn H. Case control studies. In: Veterinary Epidemiologic Research. Prince Edward Island, Canada: AVC Inc. 2003; 163-75.
25. Hosmer DW, Lemeshow S. Logistic regression for matched case-control studies. In: Applied Logistic Regression. New York: John Wiley & Sons, 1989; 187-215.
26. Winkelmann RK, Rajka G. Atopic dermatitis and Hodgkin's disease. Acta Dermato-Venereologica (Stockholm) 1983; 63: 176-7.
27. Fivenson DP, Beck ER, Dunstan RW et al. Dermal dendrocytes and T cell in canine mycosis fungoides: support for an animal model of human cutaneous T cell lymphoma. Cancer 1992; 70: 2091-8.
28. Schlaeger M. Immunoglobulin E in cutaneous lymphomas and in parapsoriasis en plaques. Dermatologica 1980; 161: 1-7.
29. Tokura Y, Yagi H, Ohshima A et al. Cutaneous colonization with staphylococci influences the disease activity of Sezary syndrome: a potential role for bacterial superantigens. British Journal of Dermatology 1995; 133: 6-12.
30. Fivenson DP, Saed GM, Beck ER et al. T-cell receptor gene rearrangement in canine mycosis fungoides; further support for a canine model of cutaneous T-cell lymphoma. Journal of Investigative Dermatology 1994; 102: 227-30.
31. Heald P, Rook A, Perez M et al. Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. Journal of American Academy of Dermatology 1992; 27: 427-33.
32. Ferenczi K, Yawalkar N, Jones D et al. Monitoring the decrease of circulating malignant T cell in cutaneous T-cell lymphoma during photopheresis and interferon therapy. Archives of Dermatology 2003; 139: 909-13.
33. Jones D, Dang NH, Duvic M et al. Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. American Journal of Clinical Pathology 2001; 115: 885-92.
34. Scala E, Narducci MG, Amerio P et al. T cell receptor-Vbeta analysis identifies a dominant CD60+CD26?CD49d? T cell clone in the peripheral blood of Sézary syndrome patients. Journal of Investigative Dermatology 2002; 119: 193-6.
35. Neish C, Charlry M, Jegasothy B et al. Proliferation cell nuclear antigen and soluble interleukin 2 receptor levels in cutaneous T cell lymphoma: correlation with advanced clinical diseases. Journal of Dermatological Science 1994; 8: 11-7.
36. Yamamoto J, Adachi Y, Onoue Y et al. CD30 expression on circulating memory CD4+ T cell as a Th2-dominated situation in patients with atopic dermatitis. Allergy 2000; 55: 1011-8.
37. Olivry T, Moore PF, Affolter VK et al. Langerhans cell hyperplasia and IgE expression in canine atopic dermatitis. Archives of Dermatological Research 1996; 288: 579-85.
38. Olivry T, Dunston SM, Murphy KM et al. Characterization of the inflammatory infiltrate during IgE-mediated late phase reactions in the skin of normal and atopic dogs. Veterinary Dermatology 2001; 12: 49-58.
39. Cooper KD, Stevenson SR. T cells in atopic dermatitis. Journal of American Academy of Dermatology 2001; 45S: 10-2.
40. Reinhold U, Kukel S, Goeden B et al. Functional characterization of skin-infiltrating lymphocytes in atopic dermatitis. Clinical and Experimental Immunology 1991; 86: 444-8.
41. Akdis CA, Akdis M, Simon HU et al. Regulation of allergic inflammation by skin-homing T cells in allergic eczema. International Archives of Allergy and Immunology 1999; 118: 140-4.
42. Sigurdsson V, Toonstra J, Bihari IC et al. Interleukin 4 and interferon-gamma expression of the dermal infiltrate in patients with erythroderma and mycosis fungoides. An immuno-histochemical study. Journal of Cutaneous Pathology 2000; 27: 429-35.
43. Kawahira K. Immunohistochemical staining of proliferating cell nuclear antigen (PCNA) in malignant and nonmalignant skin diseases. Archives of Dermatological Research 1999; 291: 413-8.
44. Nagatani T, Matsuzaki T, Lemoto G et al. Comparative study of cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma: clinical, histopathologic, and immunohistochemical analyses. Cancer 1990; 66: 2380-6.
45. Sinke JD, Thepen T, Bihari IC et al. Immunophenotyping of skin-infiltrating T-cell subsets in dogs with atopic dermatitis. Veterinary Immunology and Immunopathology 1997; 57: 13-23.
46. Olivry T, Naydan DK, Moore PF. Characterization of the cutaneous inflammatory infiltrate in canine atopic dermatitis. American Journal of Dermatopathology 1997; 19: 477-86.
47. Sinke JD, Rutten VPMG, Willemse T. Immune dysregulation in atopic dermatitis. Veterinary Immunology and Immunopathology 2002; 87: 351-6.
48. Schultz Larsen F. The epidemiology of atopic dermatitis. Monograph of Allergy 1993; 31: 196-200.
49. Guilhou JJ, Clot J, Robinet-Levy M et al. IgE and cellular immunity in cutaneous lymphomas. Annals of Dermatology and Venereology 1977; 104: 533-7.
50. Palermo A, Moretti S, Difonzo EM et al. Mycosis fungoides with monoclonal gammopathy, hypereosinophilia, and hyper-IgE. Dermatologica 1984; 169: 194-6.
51. Williams GT, Smith CA. Molecular regulation of apoptosis: genetic controls on cell death. Cell 1993; 74: 777-9.
52. Breuckmann F, von Kobyletzki G, Avermaete A et al. Efficacy of ultraviolet A1 phototherapy on the expression of bcl-2 in atopic dermatitis and cutaneous T-cell lymphoma in vivo: a comparison study. Photodermatology, Photoimmunology & Photomedicine 2002; 18: 217-22.
53. Kay AB. Allergic diseases and their treatment. New England Journal of Medicine 2001; 344: 109-13.
54. Tokura Y, Heald PW, Tan SL et al. Stimulation of cutaneous T-cell lymphoma cells with superantigenic staphylococcal toxins. Journal of Investigative Dermatology 1992; 98: 33-7.
55. Bos JD, Kapsenberg ML, Sillevis Smitt JH. Pathogenesis of atopic eczema. Lancet 1994; 343: 1338-41.
56. Leung DYM. The immunologic basis of Atopic dermatitis. Clinical Review of Allergy 1993; 11: 447-69.
57. Cole GW, Silverberg NL. The adherence of Staphylococcus aureus to human corneocytes. Archives of Dermatology 1986; 122: 166-9.
58. McEwan NA. Adherence by Staphylococcus intermedius to canine keratinocytes in atopic dermatitis. Research in Veterinary Science 2000; 68: 279-83.
59. McEwan NA, Kalna G, Mellor D. A comparison of adherence by four strains of Staphylococcus intermedius and Staphylococcus hominis to canine corneocytes collected from normal dogs and dogs suffering from atopic dermatitis. Research in Veterinary Science 2005; 78: 193-8.
60. Bibel DJ, Aly R, Shinfield HR et al. Importance of the keratinised epithelial cell in the bacterial adherence. Journal of Investigative Dermatology 1982; 79: 250-3.
61. Kanzaki H, Morishita Y, Akiyama H et al. Adhesion of Staphylococcus aureus to horny layer: role of fibrinogen. Journal of Dermatological Science 1996; 12: 132-9.
62. Magro CM, Crowson AN. Drugs with antihistaminic properties as a cause of atypical cutaneous lymphoid hyperplasia. Journal of American Academy of Dermatology 1995; 32: 419-28.
63. Magro CM, Crowson AN. Drug-induced immune dysregulation as a cause of atypical cutaneous lymphoid infiltrates: a hypothesis. Human Pathology 1996; 27: 125-32.